CN106309555A - Composite medicine containing liquorice roots, cinnamon and ceftiofur sodium for beasts and birds - Google Patents

Composite medicine containing liquorice roots, cinnamon and ceftiofur sodium for beasts and birds Download PDF

Info

Publication number
CN106309555A
CN106309555A CN201610839493.7A CN201610839493A CN106309555A CN 106309555 A CN106309555 A CN 106309555A CN 201610839493 A CN201610839493 A CN 201610839493A CN 106309555 A CN106309555 A CN 106309555A
Authority
CN
China
Prior art keywords
radix glycyrrhizae
cortex cinnamomi
drug resistance
ceftiofur sodium
cinnamon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610839493.7A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University
Original Assignee
Guangxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University filed Critical Guangxi University
Priority to CN201610839493.7A priority Critical patent/CN106309555A/en
Publication of CN106309555A publication Critical patent/CN106309555A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to composite medicine containing liquorice roots, cinnamon and ceftiofur sodium for beasts and birds. The composite medicine is prepared from the ceftiofur sodium, the liquorice roots and the cinnamon according to the weight ratio of 1:(20 to 30): (4 to 5). The invention also provides a compound preparation prepared by using the composite medicine for beasts and birds. The composite medicine has the beneficial effects that experiment study proves that when the ceftiofur sodium, the liquorice roots and the cinnamon are used in a combined way at a specific weight proportion, the synergistic effect is obvious; the curative effect taking speed is high; the cost is low, and the like.

Description

A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and ceftiofur sodium
Technical field
The invention belongs to poultry compound medicine technical field, particularly relate to a kind of containing Radix Glycyrrhizae, Cortex Cinnamomi and ceftiofur sodium Poultry compound medicine, infected, by colon bacillus, the disease that causes for treating poultry.
Background technology
Radix Glycyrrhizae is pulse family Glycyrrhiza perennial herb, and the root and rhizome of Radix Glycyrrhizae has invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, eliminates the phlegm Many effects such as cough-relieving, relieving spasm to stop pain, the mediation property of medicine, raising animal body immunity.At present, the root and rhizome of Radix Glycyrrhizae frequently as in Medical herbs feed additive, medicine source is enriched, is had no side effect in animal body, almost without residual, does not the most produce drug resistance, collects nutrition Keep healthy, prevent disease, seasoning flavouring, promote Production of Livestock and Poultry and improve animal meat quality in one.Radix Glycyrrhizae root and rhizome is raised poultry Feed additives not only has stimulating appetite, strengthening digestion, improve local flavor, function that growth promotion is fattened, and there is prevention and control Treating the function of multiple livestock and poultry, research shows, adds Radix Glycyrrhizae and can promote growth of animals or poultry, eat for a long time in additive for farm animal feed With making poultry fur light, domestic animal gets fat soon, and poultry egg laying is many.Radix Glycyrrhizae adds in the Chinese medicine fodder of prevention and treatment common diseases of chickens When adding in agent application, have that prophylactic treatment is effective, without any side effects, raw material is easy to get, cheap advantage.Additionally, Radix Glycyrrhizae root and rhizome can be additionally used in the poisoning of piglet furazolidone, domestic animal eats the poisoning of the animal such as toxic plant poisoning, pig mouldy cron poisoning by mistake Rescue, rescued effect is preferable.Radix Glycyrrhizae root and rhizome can be used for the treatment and prevention of multiple livestock and poultry as veterinary medicine, and obtains Extraordinary treatment and prevention effect.
After poultry are infected by colon bacillus, the multiple locations such as acute sepsis, peritonitis, hepatitis, pneumonia, enteritis can be caused Severe infections, causes huge economic loss to livestock and poultry cultivation.Amoxicillin, norfloxacin, florfenicol etc. are to prevent and treat this type of The conventional Western medicine of disease, along with medication is more and more spread unchecked, its Resistant strain is the most, and drug cost is the most increasing, but Therapeutic effect and drug resistance situation are not taken a turn for the better, and go from bad to worse on the contrary.
Through retrieval, do not inquire to combine Radix Glycyrrhizae, Cortex Cinnamomi and Western medicine and infected by colon bacillus for treating poultry The relevant report of the disease caused.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of poultry compound medicines containing Radix Glycyrrhizae, Cortex Cinnamomi and ceftiofur sodium Thing, its synergism is obvious, it is possible to eliminate the colon bacillus drug resistance to ceftiofur sodium, improves therapeutic effect.
For solving above technical problem, the present invention by the following technical solutions: a kind of containing Radix Glycyrrhizae, Cortex Cinnamomi and ceftiofur sodium Poultry compound medicine, be made up of ceftiofur sodium and Radix Glycyrrhizae, Cortex Cinnamomi, the weight ratio of ceftiofur sodium and Radix Glycyrrhizae, Cortex Cinnamomi is 1:20-30:4-5。
The present invention is also claimed by the compound preparation become prepared by above-mentioned poultry compound medicine.
The present invention possesses and provides the benefit that: prove through experimental study, and ceftiofur sodium and Radix Glycyrrhizae, Cortex Cinnamomi are with specific weight Amount ratio is used in combination, and has synergism obvious, and curative effect is fast, low cost and other advantages.
Detailed description of the invention
Below in conjunction with specific embodiment, technical scheme and beneficial effect are described further, except Special Statement Outward, Radix Glycyrrhizae of the present invention, Cortex Cinnamomi weight are dry weight.
One, Radix Glycyrrhizae, the Cortex Cinnamomi mensuration to the drug resistance elimination effect of Western medicine
1. assay method
It is 1:10:1,1:20:2,1:20:5,1:30:5,1:25:4,1:40 according to the weight ratio of Western medicine and Radix Glycyrrhizae, Cortex Cinnamomi: 5 prepare Western medicine and Radix Glycyrrhizae, the admixing medical solutions of Cortex Cinnamomi respectively;Choose the bacterial strain to Western medicine drug resistance as subjects, utilize flat board Dilution method carries out Secondary Culture, measures each process medicinal liquid MIC situation of change to Resistant strain;Set Radix Glycyrrhizae, Cortex Cinnamomi, each west simultaneously Prescription agent is sun comparison, compares as the moon if being not added with any medicine.
Above-mentioned process was cultivated for 3 generations the most continuously.
2. result of the test
After cultivating for 3 generations continuously, the process flat board of cloudy comparison is long bacterium, and other each medicaments and admixing medical solutions are for large intestine angstrom The result statistics of the MIC (μ g/mL) of uncommon Salmonella is as shown in table 1:
Can be concluded that by upper table
1. when the weight ratio of amoxicillin and Radix Glycyrrhizae, Cortex Cinnamomi is 1:20:2,1:20:5,1:30:5 and 1:25:4, A Mo XiLin all reduces more than 32 times to the minimal inhibitory concentration of drug resistance colon bacillus, it is seen then that drug resistance colon bacillus to Ah The drug resistance of Amdinocillin substantially reduces.And when the weight ratio of amoxicillin and Radix Glycyrrhizae, Cortex Cinnamomi is 1:10:1 and 1:40:5, A Mo The minimal inhibitory concentration of drug resistance colon bacillus compared with sun comparison (pure Western medicine) being not added with Radix Glycyrrhizae, Cortex Cinnamomi, is not had by XiLin Significant change.
2., when the weight ratio of florfenicol and Radix Glycyrrhizae, Cortex Cinnamomi is 1:20:5,1:30:5 and 1:25:4, florfenicol is to resistance to The minimal inhibitory concentration of medicine colon bacillus all reduces more than 64 times, it is seen then that drug resistance colon bacillus is to florfenicol Drug resistance substantially reduces.And when the weight ratio of florfenicol and Radix Glycyrrhizae, Cortex Cinnamomi is 1:10:1,1:20:2 and 1:40:5, fluorobenzene Buddhist nun examine the minimal inhibitory concentration to drug resistance colon bacillus be not added with Radix Glycyrrhizae, Cortex Cinnamomi sun comparison (pure Western medicine) compared with, do not have Significant change.
3., when the weight ratio of colistin and Radix Glycyrrhizae, Cortex Cinnamomi is 1:20:2,1:20:5,1:30:5, colistin is to resistance to The minimal inhibitory concentration of medicine colon bacillus all reduces more than 256 times, it is seen then that drug resistance colon bacillus is to colistin Drug resistance substantially reduces.And when the weight ratio of colistin and Radix Glycyrrhizae, Cortex Cinnamomi is 1:10:1,1:25:4 and 1:40:5, viscous bar The minimal inhibitory concentration of drug resistance colon bacillus compared with sun comparison (pure Western medicine) being not added with Radix Glycyrrhizae, Cortex Cinnamomi, is not had by rhzomorph Significant change.
4. when the weight ratio of amikacin and Radix Glycyrrhizae, Cortex Cinnamomi is 1:10:1,1:20:2,1:20:5,1:30:5, A meter Ka Star all reduces more than 128 times to the minimal inhibitory concentration of drug resistance colon bacillus, it is seen then that drug resistance colon bacillus is to Ah rice The drug resistance of card star substantially reduces.And when the weight ratio of amikacin and Radix Glycyrrhizae, Cortex Cinnamomi is 1:25:4 and 1:40:5, A meter Ka Star to the minimal inhibitory concentration of drug resistance colon bacillus compared with sun comparison (pure Western medicine) being not added with Radix Glycyrrhizae, Cortex Cinnamomi, the brightest Aobvious change.
5. when the weight ratio of sulfamonomethoxine sodium and Radix Glycyrrhizae, Cortex Cinnamomi is 1:20:2,1:20:5,1:30:5, sulfanilamide Between Sulfamonomethoxine sodium the minimal inhibitory concentration of drug resistance colon bacillus is all reduced more than 128 times, it is seen then that drug resistance large intestine angstrom wish The drug resistance of sulfamonomethoxine sodium is substantially reduced by Salmonella.And when sulfamonomethoxine sodium and Radix Glycyrrhizae, the weight of Cortex Cinnamomi When ratio is for 1:10:1,1:25:4 and 1:40:5, the sulfamonomethoxine sodium minimal inhibitory concentration to drug resistance colon bacillus Compared with sun comparison (pure Western medicine) being not added with Radix Glycyrrhizae, Cortex Cinnamomi, there is no significant change.
6. when the weight ratio of LIJUNJING and Radix Glycyrrhizae, Cortex Cinnamomi is 1:10:1,1:20:2,1:20:5,1:30:5, LIJUNJING pair The minimal inhibitory concentration of drug resistance colon bacillus all reduces more than 320 times, it is seen then that drug resistance colon bacillus is to LIJUNJING Drug resistance substantially reduces.And when the weight ratio of LIJUNJING and Radix Glycyrrhizae, Cortex Cinnamomi is and when 1:25:4,1:40:5, and LIJUNJING is to drug resistance The minimal inhibitory concentration of colon bacillus, compared with sun comparison (pure Western medicine) being not added with Radix Glycyrrhizae, Cortex Cinnamomi, does not has significant change.
7., when the weight ratio of norfloxacin and Radix Glycyrrhizae, Cortex Cinnamomi is 1:20:5, norfloxacin is to drug resistance colon bacillus Minimal inhibitory concentration all reduce more than 320 times, it is seen then that the drug resistance of norfloxacin is substantially dropped by drug resistance colon bacillus Low.And when the weight ratio of norfloxacin and Radix Glycyrrhizae, Cortex Cinnamomi is 1:20:2,1:10:1,1:30:5,1:25:4 and 1:40:5, promise The minimal inhibitory concentration of drug resistance colon bacillus compared with sun comparison (pure Western medicine) being not added with Radix Glycyrrhizae, Cortex Cinnamomi, is not had by Flucloxacillin There is significant change.
8. when the weight ratio of ceftiofur sodium and Radix Glycyrrhizae, Cortex Cinnamomi is 1:20:5,1:30:5 and 1:25:4, ceftiofur sodium The minimal inhibitory concentration of drug resistance colon bacillus is all reduced more than 32 times, it is seen then that drug resistance colon bacillus is to cephalo thiophene The drug resistance of furan sodium substantially reduces.And when the weight ratio of ceftiofur sodium and Radix Glycyrrhizae, Cortex Cinnamomi is 1:10:1,1:20:2 and 1:40:5 Time, ceftiofur sodium to the minimal inhibitory concentration of drug resistance colon bacillus be not added with Radix Glycyrrhizae, the sun of Cortex Cinnamomi compares (pure Western medicine) Compare, there is no significant change.
9. the combination weight ratio working as fosfomycin and Radix Glycyrrhizae, Cortex Cinnamomi is 1:10:1,1:20:2,1:20:5,1:30:5,1:25: 4, during 1:40:5, to the minimal inhibitory concentration of drug resistance colon bacillus be not added with Radix Glycyrrhizae, the sun of Cortex Cinnamomi compares (pure Western medicine) phase Ratio, does not has significant change.
Two, the experiment in vitro that Western medicine and Radix Glycyrrhizae, Cortex Cinnamomi are used in combination
By amoxicillin, florfenicol, colistin, amikacin, sulfamonomethoxine sodium, LIJUNJING, promise fluorine sand Star, 8 kinds of Western medicine of ceftiofur sodium are that 1:20:5 mixes with Radix Glycyrrhizae (powder) and Cortex Cinnamomi (powder) according to weight ratio respectively, make powder, Respectively as test group 1#-8#;Separately set amoxicillin, florfenicol, colistin, amikacin, sulfamonomethoxine sodium, LIJUNJING, norfloxacin, ceftiofur sodium, Radix Glycyrrhizae single dose, Cortex Cinnamomi single dose, Radix Glycyrrhizae+Cortex Cinnamomi (20:5) are respectively as matched group 1#- 11#。
Subjects is the chicken group making a definite diagnosis and having infected E.coli from chickens disease.
Morbidity chicken group is divided into 19 groups of administrations.The equal SM of each group 5 days.
Dosage and result of the test are as shown in the table:

Claims (2)

1. one kind containing Radix Glycyrrhizae, Cortex Cinnamomi and the poultry compound medicine of ceftiofur sodium, it is characterised in that by ceftiofur sodium and sweet Grass, Cortex Cinnamomi composition, the weight ratio of ceftiofur sodium and Radix Glycyrrhizae, Cortex Cinnamomi is 1:20-30:4-5.
2. by the compound preparation become prepared by the poultry compound medicine described in claim 1.
CN201610839493.7A 2016-09-21 2016-09-21 Composite medicine containing liquorice roots, cinnamon and ceftiofur sodium for beasts and birds Withdrawn CN106309555A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610839493.7A CN106309555A (en) 2016-09-21 2016-09-21 Composite medicine containing liquorice roots, cinnamon and ceftiofur sodium for beasts and birds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610839493.7A CN106309555A (en) 2016-09-21 2016-09-21 Composite medicine containing liquorice roots, cinnamon and ceftiofur sodium for beasts and birds

Publications (1)

Publication Number Publication Date
CN106309555A true CN106309555A (en) 2017-01-11

Family

ID=57819583

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610839493.7A Withdrawn CN106309555A (en) 2016-09-21 2016-09-21 Composite medicine containing liquorice roots, cinnamon and ceftiofur sodium for beasts and birds

Country Status (1)

Country Link
CN (1) CN106309555A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103948930A (en) * 2014-05-14 2014-07-30 广西大学 Red paeonia/beta-lactam-antibacterial-agent-containing compound medicine for livestock and fowl
CN104306422A (en) * 2014-11-07 2015-01-28 广西大学 Balsamiferou Blumea herb and beta-lactam antibacterial drug containing compound medicine for livestock and poultry
CN104435011A (en) * 2014-11-12 2015-03-25 广西大学 Compound medicine containing herba pteridis multifidae and beta-lactam antibiotics drugs for livestock and poultry

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103948930A (en) * 2014-05-14 2014-07-30 广西大学 Red paeonia/beta-lactam-antibacterial-agent-containing compound medicine for livestock and fowl
CN104306422A (en) * 2014-11-07 2015-01-28 广西大学 Balsamiferou Blumea herb and beta-lactam antibacterial drug containing compound medicine for livestock and poultry
CN104435011A (en) * 2014-11-12 2015-03-25 广西大学 Compound medicine containing herba pteridis multifidae and beta-lactam antibiotics drugs for livestock and poultry

Similar Documents

Publication Publication Date Title
CN103238756A (en) Compound feed for finishing pigs and preparation method thereof
CN104366117A (en) Composite quail feed
CN104800819A (en) Traditional Chinese medicine preparation for treating fowl plague
CN105535198A (en) Traditional Chinese medicine composition for treating poultry hydropericardium
CN106511675A (en) Medicine for preventing and treating poultry diseases and preparation method of medicine
CN105166450A (en) Dairy cow feed for preventing and treating mastitis and preparation method thereof
CN106109579A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and amoxicillin
CN105231054A (en) Medicinal feedstuff preventing and treating mink cold disease
CN105560444B (en) Tibetan medicine composition for treating yak gastroenteritis and preparation method and application thereof
CN106309555A (en) Composite medicine containing liquorice roots, cinnamon and ceftiofur sodium for beasts and birds
CN106138184A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and amoxicillin
CN106236836A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and florfenicol
CN106265921A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and sulfamonomethoxine sodium
CN106176945A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and LIJUNJING
CN106267155A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and colistin
CN106265920A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and norfloxacin
CN106265919A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae, Cortex Cinnamomi and amikacin
CN106265880A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and ceftiofur sodium
CN102894200A (en) Foodstuff additive used for enhancing sheep antibiosis and anti-virus, and preparation method thereof
CN101326968B (en) Animal feed additives using Zedoary turmeric oil as principal ingredient and preparation thereof
CN102961563B (en) Pharmaceutical composition for treating livestock and poultry dysentery and preparation method thereof
CN107789394B (en) Composition for treating livestock and poultry diarrhea
CN106107114A (en) A kind of pig's feed additive and preparation method thereof
CN112120123A (en) Chinese herbal medicine feed additive for preventing and treating common diseases and frequently encountered diseases of meat rabbits as well as preparation method and application thereof
CN110338285A (en) A kind of mongolian veterinary drug feed addictive and preparation method and application for preventing and treating pneumonia of sheep

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170111